Repligen (RGEN) Return on Capital Employed (2011 - 2026)
Repligen (RGEN) posted quarterly Return on Capital Employed of 2.3% for Q2 2026, up 317.0% year-over-year from 0.55% in Q2 2025, and little changed quarter-over-quarter from 2.29% in Q1 2026.
Repligen (RGEN) Return on Capital Employed (2011 - 2026) Analysis & Trends
Repligen (RGEN) has reported Return on Capital Employed for 16 consecutive years, with 2.3% the latest figure, recorded in Q2 2026.
- In Q2 2026, Return on Capital Employed rose 317.0% year-over-year to 2.3%; the TTM figure through Jun 2026 stood at 2.3% (up 317.0% YoY), while the FY2025 annual figure was 2.0%, up 330.0% from the prior year.
- Return on Capital Employed held at 2.3% in Q2 2026 per RGEN's latest filing, from 2.29% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 10.74% in Q4 2022 and bottomed at 1.3% in Q4 2024.
- Historically, Return on Capital Employed has averaged 3.77% across 5 years, with a median of 2.13% in 2026.
- Annual changes were most pronounced in 2022 — Return on Capital Employed surged 392 bps — and 2023, when it sank 884 bps.
- Repligen's Return on Capital Employed stood at 10.74% in 2022, then sank by 82 bps to 1.9% in 2023, then slumped by 168 bps to 1.3% in 2024, then jumped by 252 bps to 1.97% in 2025, then advanced by 17 bps to 2.3% in 2026.
- Business Quant data shows RGEN's Return on Capital Employed at 2.3% in Q2 2026, 2.29% in Q1 2026, and 1.97% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.58% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 6.00% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 28.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.22% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 5.57% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 19.71% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 19.76% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 4.68% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.28% |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 2.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30% |
| Mar 31, 2026 | 2.29% |
| Dec 31, 2025 | 1.97% |
| Sep 30, 2025 | 0.03% |
| Jun 30, 2025 | -0.87% |
| Mar 31, 2025 | -1.20% |
| Dec 31, 2024 | -1.30% |
| Sep 30, 2024 | 0.41% |
| Jun 30, 2024 | 0.89% |
| Mar 31, 2024 | 1.41% |
| Dec 31, 2023 | 1.90% |
| Sep 30, 2023 | 4.01% |
| Jun 30, 2023 | 6.22% |
| Mar 31, 2023 | 8.41% |
| Dec 31, 2022 | 10.74% |
| Sep 30, 2022 | 10.44% |
| Jun 30, 2022 | 10.34% |
| Mar 31, 2022 | 9.80% |
| Dec 31, 2021 | 8.69% |
| Sep 30, 2021 | 8.28% |